Clinical Trials Browser

Phase 3 × Withdrawn × XELOX × Clear all

NCT01470742 2019-12-30

Trial Comparing Capecitabine Plus Oxaliplatin (XELOX) and Capecitabine (X) as First-line Chemotherapy in Elderly Patients With Advanced Gastric Cancer

Phase 3 Withdrawn

Gastrointestinal

Stomach Neoplasms